Mergers and acquisitions – Page 16
-
Business
Jazz spending spree has ups and downs
Aerial sells Jazz rights to sleeping sickness drug but Gentium shareholders put brakes on earlier deal
-
Business
Thermo Fisher to sell three analytical divisions to GE Healthcare
Deal will help the firm complete its ongoing takeover of Life Technologies
-
-
-
Business
Kemira now water-based after formic acid sale
Business sold to US agrichemical for €140 million
-
Business
AstraZeneca shells out $4.1bn for diabetes business
Bristol-Myers Squibb exits the diabetes field with plans to become a specialised biopharmaceutical company
-
Business
Merck KGaA snaps up electronic materials specialist
Firm looks to bolster R&D by acquiring AZ Electronic Materials
-
Business
Pfizer teams up with GSK in cancer drug trial
Two companies will collaborate to develop a combination therapy for melanoma
-
Business
DSM to spin out pharma unit
Firm will combine with Patheon to provide manufacturing services
-
BusinessRapid DNA sequencing cleared for the clinic
Illumina’s ‘next-generation’ MiSeqDx platform gets US approval
-
Business
Novartis sells off blood diagnostics division
$1.7bn deal reinforces firm’s focus on core pharmaceuticals
-
Business
Shire will cut UK R&D to focus on rare diseases
$4.2bn buyout of ViroPharma bolsters pipeline, while Basingstoke site halts research
-
Business
Solvay expands surfactants business with Chemlogics buyout
$1.3bn deal brings firm into booming US oil and gas drilling market
-
Business
Aspen acquires anticoagulant brands
South African drugmaker buys thrombosis drugs from GSK for £700m
-
Business
Clariant expands into China
Firm buys pigments arm of Jiangsu Multicolor and will build new plant
-
Business
Algal oil producer steps up supply
Solazyme to provide 10,000 tonnes of tailored oil to Unilever
-
Business
Nanobody inflammation drug attracts Abbvie
$840m licensing deal shows support for antibody fragments